Sailan Wen

Renmin Road 139
Changsha, 410000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Aberrant CEACAM19 expression is associated with metastatic phenotype in penile cancer.

Aberrant CEACAM19 expression is associated with metastatic phenotype in penile cancer.

Journal: Cancer management and research

Published: January 26, 2019

Long non-coding RNA DLX6-AS1 silencing inhibits malignant phenotypes of gastric cancer cells.

Long non-coding RNA DLX6-AS1 silencing inhibits malignant phenotypes of gastric cancer cells.

Journal: Experimental and therapeutic medicine

Published: August 16, 2018

Overexpression of ID1 promotes tumor progression in penile squamous cell carcinoma.

Overexpression of ID1 promotes tumor progression in penile squamous cell carcinoma.

Journal: Oncology reports

Published: July 05, 2018

Comparison of efficacy between brachytherapy and penectomy in patients with penile cancer: a meta-analysis.

Comparison of efficacy between brachytherapy and penectomy in patients with penile cancer: a meta-analysis.

Journal: Oncotarget

Published: April 07, 2017

Phosphorylation of Bcl-2 plays an important role in glycochenodeoxycholate-induced survival and chemoresistance in HCC.

Phosphorylation of Bcl-2 plays an important role in glycochenodeoxycholate-induced survival and chemoresistance in HCC.

Journal: Oncology reports

Published: December 06, 2016

Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.

Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.

Journal: Oncotarget

Published: May 05, 2016

Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma.

Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma.

Journal: Diagnostic pathology

Published: April 20, 2016

Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.

Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.

Journal: Oncology reports

Published: March 01, 2016

Expression of miR-224, miR-145, and their putative target ADAM17 in hepatocellular carcinoma.

Expression of miR-224, miR-145, and their putative target ADAM17 in hepatocellular carcinoma.

Journal: Acta biochimica et biophysica Sinica

Published: June 28, 2014

Loss of plexin-B3 in hepatocellular carcinoma.

Loss of plexin-B3 in hepatocellular carcinoma.

Journal: Experimental and therapeutic medicine

Published: May 05, 2014

MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma.

MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma.

Journal: Oncology reports

Published: April 13, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026